An experimental drug shows promise in protecting heart function for muscular dystrophy patients by reducing...
Bispecific antibodies are emerging immunotherapy for relapsed lymphoma and leukemia, offering a viable option when...
Heart failure management is shifting as pharmacists take on a larger role. Discover how they...
Proton pump inhibitors may reduce the benefit of durvalumab consolidation after chemoradiotherapy for unresectable stage...
GLP-1 receptor agonists can interact with oral chemotherapy, jeopardizing treatment effectiveness for diabetes and weight...
FDA approves Leqembi home administration. Learn about the new starting dosage regimen for subcutaneous lecanemab...
Learn why bispecific T-cell therapy for multiple myeloma may face access restrictions and how patient...
A groundbreaking drug for resistant hypertension offers hope to patients unresponsive to standard treatments, targeting...
Menin inhibitors offer new hope for AML treatment by targeting molecular drivers in 40% of...